risk of medullary thyroid cancer with glp 1 GLP-1 Receptor Agonists and Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence thyroid GLP-1 RAs and Thyroid Cancer:

Al-Majed and colleagues [140] found that carnitine deficiency and oxidative stress are risk factors during development of cisplatin (CDDP)-induced cardiomyopathy and that carnitine supplementation, using propionyl-l-carnitine, prevents the progression of CDDP-induced cardiotoxicity

They found that adolescents between the ages of 13 and 17 are frequent targets of energy-drink marketing, and stated in a written report that this population is also at risk for the detrimental impacts of energy-drink consumption. The report also noted a range of claims not evaluated or substantiated by the FDA

Semax rapidly increases BDNF and its receptor TrkB in the hippocampus, the brain region most critical for memory formation

578 ForsythLMPreussHGMacDowellALChiazzeLJr.BirkmayerGDBellantiJA

Boston, MA Frequently asked questions In the SURMOUNT-1 trial published in The New England Journal of Medicine (Jastreboff et al., 2022), participants on weekly tirzepatide 15 mg lost an average of 20.9% of body weight at 72 weeks versus 3.1% on placebo

Enhanced Liver Fibrosis test or transient elastography if indicated)